Zentalis Pharmaceuticals, Inc.
ZNTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001725160
In the last 90 days, Zentalis Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 114 institutions reported holding it in 13F filings for Q2 2026, worth $228.9M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Zentalis Pharmaceuticals, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 99
- −18 vs. Q2 2025
- Shares held
- 52.8M
- −2.82M (−5.1%) vs. Q2 2025
- Total value
- $79.7M
- +$15.2M (+23.5%) vs. Q2 2025
- New holders
- 5
- 36 more added
- Sold out
- 23
- 33 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZNTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 114 | $228.9M |
| Q1 2026 | 102 | $101.7M |
| Q4 2025 | 86 | $54.9M |
| Q3 2025 | 99 | $79.7M |
| Q2 2025 | 117 | $64.5M |
| Q1 2025 | 132 | $92.9M |
| Q4 2024 | 142 | $195.2M |
| Q3 2024 | 136 | $261.2M |
| Q2 2024 | 145 | $314.3M |
| Q1 2024 | 142 | $1.34B |
| Q4 2023 | 120 | $1.23B |
| Q3 2023 | 137 | $1.61B |
| Q2 2023 | 134 | $2.32B |
| Q1 2023 | 110 | $1.15B |
| Q4 2022 | 106 | $1.30B |
| Q3 2022 | 121 | $1.27B |
| Q2 2022 | 122 | $1.64B |
| Q1 2022 | 128 | $2.05B |
| Q4 2021 | 139 | $3.61B |
| Q3 2021 | 116 | $2.75B |
| Q2 2021 | 120 | $2.13B |
| Q1 2021 | 95 | $1.58B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Zentalis Pharmaceuticals, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −150,990−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −73,797−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −72,261−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −70,641−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −41,454−100.0% | Sold out |
| CI Private Wealth, LLC | 0 | $0 | 0.00% | −35,760−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −32,740−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −27,877−100.0% | Sold out |
| DRW Securities, LLC | 0 | $0 | 0.00% | −16,830−100.0% | Sold out |
| Hudson Bay Capital Management LP | 0 | $0 | 0.00% | −16,638−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −11,692−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −10,808−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −10,546−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,699−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −2,278−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,271−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −1,164−100.0% | Sold out |
| Essential Partners LLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| True Wealth Design, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |